Program: Education Program
Session: Optimizing Non-Curative Therapies for Sickle Cell Disease
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Combination therapy, Adult, Clinical Practice (Health Services and Quality), Hemoglobinopathies, Pediatric, Diseases, Treatment Considerations, Young adult , Study Population, Human
Session: Optimizing Non-Curative Therapies for Sickle Cell Disease
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Combination therapy, Adult, Clinical Practice (Health Services and Quality), Hemoglobinopathies, Pediatric, Diseases, Treatment Considerations, Young adult , Study Population, Human
Saturday, December 7, 2024, 9:30 AM-10:45 AM
Disclosures: Brandow: Pfizer: Other: Adjudication committee for clinical trial .
See more of: Optimizing Non-Curative Therapies for Sickle Cell Disease
See more of: Education Program
See more of: Education Program